3 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow apheresis procedure: new trials by email Literature Review of apheresis procedure trials Research Report on apheresis procedure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Biological Variables Affecting CD34+ Peripheral Cells Collection Efficiency apheresis procedure - Optimize PBSC Harvest Through Automated Buffy Coat | Completed | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 113 | 2023-09-01 | 2024-03-13 | |
| Plerixafor for Stem Cell Mobilization in Normal Donors Filgrastim, Plerixafor, Apheresis Procedure - Blood And Marrow Transplantation | Phase 2 | Completed | M.D. Anderson Cancer Center | 22 | 2013-10-01 | 2019-04-23 |
| Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma NY-ESO-1 157-165 (165V), Nivolumab, gp100:280-288 (288V) - Melanoma (Skin) | Phase 1 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 73 | 2010-08-13 | 2023-07-19 |
Melanoma (1)
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · M.D. Anderson Cancer Center (1)
United States (2) · Italy (1)
Chitra M. Hosing, MD (1) · Nikhil Khushalani, M.D. (1)